Skin invasion and prognosis in node negative breast cancer: A retrospective study

World Journal of Surgical Oncology

Volumn 6, Issue , 2008, Pages

  Tada, Keiichiro ^a   Morizono, Hidetomo ^a   Iijima, Kotaro ^a   Miyagi, Yumi ^a   Nishimura, Seiichiro ^a   Makita, Masujiro ^a   Horii, Rie ^b   Akiyama, Futoshi ^b   Iwase, Takuji ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; FLUOROURACIL DERIVATIVE; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LUNG CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RETROSPECTIVE STUDY; SKIN METASTASIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR VOLUME; BREAST TUMOR; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; SKIN TUMOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 41249087237     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-6-10     Document Type: Article

References (14)

1. Sutherland CM Mather FJ Long-term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, or chest wall attachment) disease with and without positive lymph nodes Cancer 1986, 57(3):622-629. 10.1002/ 1097-0142(19860201)57:3<622::AID-CNCR2820570338<3.0.CO;2-C 3942999
2. Carter CL Allen C Henson DE Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases Cancer 1989, 63(1):181-187. 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129<3.0.CO;2-H 2910416
3. Perrone F Carlomagno C Lauria R De Laurentiis M Morabito A Panico L Pettinato G Petrella G Gallo C Bianco AR De Placido S Selecting high-risk early breast cancer patients: What to add to the number of metastatic nodes? Eur J Cancer 1996, 32A(1):41-46. 10.1016/ 0959-8049(95)00442-4 8695239
4. UICC TNM Classification of Malignant Tumours New York, Wiley-Liss L.H.Sobin CW 6th 2002
5. Iyer RV Hanlon A Fowble B Freedman G Nicolaou N Anderson P Hoffman J Sigurdson E Boraas M Torosian M Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined Int J Radiat Oncol Biol Phys 2000, 47(5):1177-1183. 10889370
6. Sastre-Garau X Jouve M Asselain B Vincent-Salomon A Beuzeboc P Dorval T Durand JC Fourquet A Pouillart P Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns Cancer 1996, 77(1):113-120. 10.1002/ (SICI)1097-0142(19960101)77:1<113::AID-CNCR19<3.0.CO;2-8 8630916
7. Fisher ER Costantino J Fisher B Redmond C Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project Investigators Cancer 1993, 71(6 Suppl):2141-2150. 10.1002/ 1097-0142(19930315)71:6+<2141::AID-CNCR2820711603<3.0.CO;2-F 8443763
8. Goldhirsch A Glick JH Gelber RD Coates AS Thurlimann B Senn HJ Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 2005, 16(10):1569-1583. 10.1093/ annonc/mdi326 16148022
9. Fan C Oh DS Wessels L Weigelt B Nuyten DS Nobel AB van't Veer LJ Perou CM Concordance among gene-expression-based predictors for breast cancer N Engl J Med 2006, 355(6):560-569. 10.1056/NEJMoa052933 16899776
10. Manders P Tjan-Heijnen VC Span PN Grebenchtchikov N Foekens JA Beex LV Sweep CG Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer Cancer Res 2004, 64(2):659-664. 10.1158/0008-5472.CAN-03-1820 14744782
11. Arpino G Weiss H Lee AV Schiff R De Placido S Osborne CK Elledge RM Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance J Natl Cancer Inst 2005, 97(17):1254-1261. 16145046
12. Keyomarsi K Tucker SL Buchholz TA Callister M Ding Y Hortobagyi GN Bedrosian I Knickerbocker C Toyofuku W Lowe M Herliczek TW Bacus SS Cyclin E and survival in patients with breast cancer N Engl J Med 2002 347 20 1566 1575 10.1056/NEJMoa021153 12432043
13. Slamon DJ Godolphin W Jones LA Holt JA Wong SG Keith DE Levin WJ Stuart SG Udove J Ullrich A Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 1989, 244(4905):707-712. 10.1126/ science.2470152 2470152
14. Silverstein MJ Lagios MD Groshen S Waisman JR Lewinsky BS Martino S Gamagami P Colburn WJ The influence of margin width on local control of ductal carcinoma in situ of the breast N Engl J Med 1999, 340(19):1455-1461. 10.1056/NEJM199905133401902 10320383